Piperine Inhibits Gastric Emptying and Gastrointestinal Transit in Rats and Mice

Abstract

Piperine (1), an alkaloid of black and long peppers, inhibited gastric emptying (GE) of solids/liquids in rats and gastrointestinal transit (GT) in mice in a dose and time dependent manner. Compound 1 significantly inhibited GE of solids and GT at the doses extrapolated from humans (1 mg/kg and 1.3 mg/kg p.o. in rats and mice, respectively). However, at the same dose the effect was insignificant for GE of liquids. One week oral treatment of 1 mg/kg and 1.3 mg/kg in rats and mice, respectively, did not produce a significant change in activity as compared to single dose administration. GE inhibitory activity of 1 is independent of gastric acid and pepsin secretion.

References

• 1 Atal C K, Zutshi U, Rao P G. Scientific evidence of the role of Ayurvedic herbals on bioavailability of drugs.  J. Ethnopharmacol.. 1981;  4 229-32
• 2 Bano G, Raina R K, Zutshi U, Bedi K L, Johri R K, Sharma S C. The effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers.  Eur. J. Clin. Pharmacol.. 1991;  41 615-7
• 3 Majeed M, Badmaev V, Ramaswamy R. Use of piperine as a bioavailability enhancer. US Patent No. 5,744,161 1998
• 4 Bano G, Amla V, Raina R K, Zutshi U, Chopra C L. The effect of piperine on pharmacokinetis of phenytoin in healthy volunteers.  Planta Medica. 1987;  53 568-9
• 5 Kapil R S, Zutshi U, Bedi K L, Singh G, Johri R K, Dhar S K et al. A process for the preparation of pharmaceutical combination with enhanced activity for the treatment of tuberculosis and leprosy. US Patent No. 5439891 1995
• 6 Bedi K L, Zutshi U, Kapoor N, Koul J L, Bano G. A process for the preparation of pharmacetuical combination with enhanced activity for the treatment of vitiligo, psoriasis, mycosis and fungoides. Indian Patent No. 176433 1993
• 7 Atal C K, Dubey R K, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metaoblism.  J. Pharm. Exp. Ther.. 1985;  232 258-62
• 8 Gibaldi M. Biopharmaceutics and Clinical pharmacokinetics. Philadelphia; Lea and Febiger 1984: 35-8
• 9 Minami H, McCallum R W. The physiology and pathophysiology of gastric emptying in humans.  Gastroenterology. 1984;  86 1592-610
• 10 Bertaccini G, Scarpignato C. Effect of some cholecystokinin (CCK) - like peptides on gastric emptying of a liquid meal in rat.  Bri. J. Pharmacol.. 1981;  72 103P-104P
• 11 Hunt J N, MacDonald I. The pattern of emptying of human stomach.  J. Physiol. (London). 1954;  126 459-74
• 12 Annamalai A R, Manavalan R. Effect of “trikatu” and its individual components and piperine on gastrointestinal tracts: Trikatu - A bioavailability enhancer.  Indian Drugs. 1989;  27 595-604
• 13 Glatzel H. Physiological aspects of flavour compounds.  Indian Spices.. 1968;  5 13
• 14 Cole O F. Pharmacological studies of piperine; I. Effects of piperine on transmural nerve stimulation.  Planta Medica. 1985;  51 153-6
• 15 Bhat G B, Chandrashekhara N. Studies on the metabolism of piperine: Absorption, tissue distribution and excretion of urinary conjugates in rats.  Toxicology. 1986;  40 83-92
• 16 Bertaccini G, Castiglone De, Scarpignato C. Effect of substance P and its analogues on the gastric emptying of the conscious rat.  Br. J. Pharmacol.. 1981;  72 221-3
• 17 Garcia-Garayoa E, Monge A, Roca J, Del Rio J, Lasheras B. VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. II. Evaluation of the gastroprokinetic activity in rats and dogs.  J. Pharm. Pharmacol.. 1997;  49 66-73
• 18 Bhattacharjee M, Bose A K, Banerjee R K. Histamine H₂-receptor mediated stimulation of gastric acid secretion by mercaptomethylimidazole.  Biochem. Pharmacol.. 1989;  381 907-14